Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)
China
· Delayed Price · Currency is CNY 20.05
-0.07 (-0.35%)
Feb 21, 2025, 3:00 PM CST
SHA:600161 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 20, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 39,646 | 50,983 | 39,103 | 39,767 | 52,310 | 29,208 | Upgrade
|
| Market Cap Growth | 17.71% | 30.38% | -1.67% | -23.98% | 79.10% | 57.78% | Upgrade
|
| Enterprise Value | 38,088 | 49,023 | 37,846 | 37,744 | 52,384 | 29,158 | Upgrade
|
| Last Close Price | 20.05 | 25.65 | 19.64 | 19.89 | 28.56 | 15.93 | Upgrade
|
| PE Ratio | 31.43 | 45.94 | 44.39 | 52.32 | 81.86 | 47.80 | Upgrade
|
| Forward PE | 24.31 | 39.63 | 39.14 | 45.04 | 67.68 | 37.76 | Upgrade
|
| PS Ratio | 7.65 | 9.84 | 9.18 | 9.67 | 15.18 | 8.90 | Upgrade
|
| PB Ratio | 3.73 | 4.00 | 3.44 | 3.87 | 8.67 | 5.64 | Upgrade
|
| P/TBV Ratio | 5.11 | 5.69 | 4.78 | 5.27 | 12.60 | 8.27 | Upgrade
|
| P/FCF Ratio | 146.93 | 38.74 | - | - | 561.25 | 251.27 | Upgrade
|
| P/OCF Ratio | 36.79 | 21.30 | 34.73 | 40.56 | 74.50 | 45.46 | Upgrade
|
| PEG Ratio | 0.62 | 0.62 | 0.62 | 0.62 | 0.62 | 0.62 | Upgrade
|
| EV/Sales Ratio | 7.28 | 9.46 | 8.88 | 9.18 | 15.20 | 8.88 | Upgrade
|
| EV/EBITDA Ratio | 16.41 | 25.12 | 26.07 | 28.75 | 44.33 | 25.36 | Upgrade
|
| EV/EBIT Ratio | 19.13 | 28.73 | 29.27 | 32.15 | 49.94 | 28.55 | Upgrade
|
| EV/FCF Ratio | 141.16 | 37.25 | - | - | 562.04 | 250.85 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.04 | 0.05 | 0.13 | 0.08 | Upgrade
|
| Debt / EBITDA Ratio | 0.02 | 0.02 | 0.27 | 0.38 | 0.68 | 0.35 | Upgrade
|
| Debt / FCF Ratio | 0.15 | 0.03 | - | - | 8.59 | 3.45 | Upgrade
|
| Asset Turnover | 0.35 | 0.38 | 0.35 | 0.43 | 0.50 | 0.58 | Upgrade
|
| Inventory Turnover | 0.80 | 0.99 | 0.97 | 1.00 | 0.85 | 0.91 | Upgrade
|
| Quick Ratio | 3.28 | 3.66 | 4.25 | 6.64 | 2.62 | 3.18 | Upgrade
|
| Current Ratio | 5.51 | 5.92 | 6.28 | 9.32 | 4.96 | 6.21 | Upgrade
|
| Return on Equity (ROE) | 13.14% | 12.52% | 11.14% | 13.12% | 16.83% | 18.78% | Upgrade
|
| Return on Assets (ROA) | 8.25% | 7.86% | 6.60% | 7.68% | 9.46% | 11.22% | Upgrade
|
| Return on Capital (ROIC) | 9.36% | 8.69% | 7.17% | 8.33% | 10.56% | 12.57% | Upgrade
|
| Return on Capital Employed (ROCE) | 14.22% | 13.22% | 10.98% | 10.90% | 15.89% | 18.04% | Upgrade
|
| Earnings Yield | 3.21% | 2.18% | 2.25% | 1.91% | 1.22% | 2.09% | Upgrade
|
| FCF Yield | 0.68% | 2.58% | -0.58% | -0.38% | 0.18% | 0.40% | Upgrade
|
| Dividend Yield | 0.62% | 0.49% | 0.21% | 0.35% | 0.24% | 0.22% | Upgrade
|
| Payout Ratio | 19.50% | 8.47% | 17.85% | 21.56% | 14.54% | 9.88% | Upgrade
|
| Buyback Yield / Dilution | -1.32% | 0.32% | -2.79% | -7.41% | -0.59% | 0.04% | Upgrade
|
| Total Shareholder Return | -0.70% | 0.81% | -2.58% | -7.06% | -0.35% | 0.26% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.